Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting

[ad_1] ROCKVILLE, Md. and SUZHOU, China, June 3, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the…

Monoclonal Antibodies Market Analysis, Trends, Business Strategy and Forecast to 2032:Abbott Laboratories, Amgen Inc., AstraZeneca plc, Bayer AG, Eli Lilly, GlaxoSmithKline Plc

[ad_1] Development Status: : In February 2022, Eli Lilly and Company announced that United States Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an…